Cargando…

Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge Infection

Neuraminidase is an important target for influenza vaccination. In this study, we generated avian influenza VLPs, expressing hemagglutinin (HA), neuraminidase (NA), HA and NA co-expressed (HANA), to evaluate the protective role of NA against a high (10LD(50)) and low (2LD(50)) dose of avian influenz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Hae-Ji, Chu, Ki-Back, Yoon, Keon-Woong, Eom, Gi-Deok, Mao, Jie, Kim, Min-Ju, Lee, Su-Hwa, Moon, Eun-Kyung, Quan, Fu-Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537550/ https://www.ncbi.nlm.nih.gov/pubmed/34684240 http://dx.doi.org/10.3390/pathogens10101291

Ejemplares similares

Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection
por: Kang, Hae-Ji, et al.
Publicado: (2022)

Cross-Protection Induced by Virus-like Particles Derived from the Influenza B Virus
por: Kang, Hae-Ji, et al.
Publicado: (2022)

Sublingual Vaccination with Live Influenza Virus Induces Better Protection Than Oral Immunization in Mice
por: Mao, Jie, et al.
Publicado: (2022)

Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of Toxoplasma gondii Infection
por: Kim, Min-Ju, et al.
Publicado: (2022)

Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei
por: Kim, Min-Ju, et al.
Publicado: (2022)

Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein
por: Eom, Gi-Deok, et al.
Publicado: (2023)

Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection
por: Lee, Su-Hwa, et al.
Publicado: (2023)

Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18
por: Yoon, Keon-Woong, et al.
Publicado: (2022)

Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains
por: Chu, Ki-Back, et al.
Publicado: (2021)

Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection
por: Yoon, Keon-Woong, et al.
Publicado: (2022)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
por: Kang, Hae-Ji, et al.
Publicado: (2019)

Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
por: Kim, Min-Ju, et al.
Publicado: (2022)

The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques
por: Kang, Hae-Ji, et al.
Publicado: (2023)

Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
por: Yoon, Keon-Woong, et al.
Publicado: (2021)

Emergence and Genetic Variation of Neuraminidase Stalk Deletions in Avian Influenza Viruses
por: Li, Jinling, et al.
Publicado: (2011)

Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus
por: Ushirogawa, Hiroshi, et al.
Publicado: (2011)

Biological Characterizations of H5Nx Avian Influenza Viruses Embodying Different Neuraminidases
por: Yu, Yuandi, et al.
Publicado: (2017)

Aurintricarboxylic acid inhibits influenza virus neuraminidase
por: Hung, Hui-Chen, et al.
Publicado: (2009)

Influenza Virus Neuraminidase: Structure and Function
por: Shtyrya, Y.A., et al.
Publicado: (2009)

Influenza Virus Neuraminidase Structure and Functions
por: McAuley, Julie L., et al.
Publicado: (2019)

Neuraminidase Subtyping of Avian Influenza Viruses with PrimerHunter-Designed Primers and Quadruplicate Primer Pools
por: Huang, Yanyan, et al.
Publicado: (2013)

Avian Influenza Virus with Hemagglutinin-Neuraminidase Combination H8N8, Isolated in Russia
por: Sivay, Mariya V., et al.
Publicado: (2014)

Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses
por: Bialy, Dagmara, et al.
Publicado: (2020)

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle
por: Kim, Ki-Hye, et al.
Publicado: (2022)

Protective Immunity Induced by Virus-Like Particle Containing Merozoite Surface Protein 9 of Plasmodium berghei
por: Lee, Su-Hwa, et al.
Publicado: (2020)

Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza
por: Ward, Melissa J, et al.
Publicado: (2013)

Correction: Neuraminidase Subtyping of Avian Influenza Viruses with PrimerHunter-Designed Primers and Quadruplicate Primer Pools
por: Huang, Yanyan, et al.
Publicado: (2013)

Inherent Serum Inhibition of Influenza Virus Neuraminidases
por: Skarlupka, Amanda L., et al.
Publicado: (2021)

Truncation or Deglycosylation of the Neuraminidase Stalk Enhances the Pathogenicity of the H5N1 Subtype Avian Influenza Virus in Mallard Ducks
por: Chen, Sujuan, et al.
Publicado: (2020)

Contribution of Neuraminidase of Influenza Viruses to the Sensitivity to Sera Inhibitors and Reassortment Efficiency
por: Kiseleva, Irina, et al.
Publicado: (2014)

Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses
por: Lee, Su-Hwa, et al.
Publicado: (2019)

Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012)

Protection induced by malaria virus-like particles containing codon-optimized AMA-1 of Plasmodium berghei
por: Lee, Dong-Hun, et al.
Publicado: (2019)

Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations
por: Kang, Hae-Ji, et al.
Publicado: (2020)

Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
por: Lee, Su-Hwa, et al.
Publicado: (2022)

Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
por: Chu, Ki-Back, et al.
Publicado: (2023)

Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?
por: Gillim-Ross, Laura, et al.
Publicado: (2007)

Virus-Like Particles Assembled Using Respiratory Syncytial Virus Matrix Protein Elicit Protective Immunity in Mice
por: Lee, Su-Hwa, et al.
Publicado: (2023)

Formation of virus-like particles from human cell lines exclusively expressing Influenza Neuraminidase
por: Lai, JCC, et al.
Publicado: (2011)

Respiratory virus deterrence induced by modified mask filter
por: Lee, Su-Hwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qis9q4ca1d8mt1pcj3ar9fkjsb